| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.004 | 0.838 | Alpha adrenoreceptor antagonist | 0.838 0.003 DBMET00379 0.297 0.016 DB12110 | DBMET00379 | |
| 0.673 | 0.004 | 0.769 | Alpha 1 adrenoreceptor antagonist | 0.769 0.003 DBMET00379 0.262 0.014 DB12110 | DBMET00379 | |
| 0.654 | 0.004 | 0.654 | 5 Hydroxytryptamine 2 antagonist | 0.613 0.004 DBMET00379 0.327 0.014 DB12110 | ||
| 0.653 | 0.005 | 0.653 | 5 Hydroxytryptamine antagonist | 0.61 0.005 DBMET00379 0.361 0.014 DB12110 | ||
| 0.568 | 0.004 | 0.568 | 5 Hydroxytryptamine 2A antagonist | 0.526 0.004 DBMET00379 0.277 0.013 DB12110 | ||
| 0.502 | 0.004 | 0.502 | 5 Hydroxytryptamine 1A antagonist | 0.371 0.006 DBMET00379 0.204 0.014 DB12110 | ||
| 0.493 | 0.004 | 0.493 | 5 Hydroxytryptamine 1A agonist | 0.317 0.005 DBMET00379 0.168 0.01 DBMET01712 0.143 0.011 DB12110 | ||
| 0.493 | 0.005 | 0.687 | Antiadrenergic | 0.687 0.004 DBMET00379 0.137 0.04 DBMET01712 0.33 0.012 DB12110 | DBMET00379 | |
| 0.491 | 0.005 | 0.686 | Adrenaline antagonist | 0.686 0.004 DBMET00379 0.134 0.039 DBMET01712 0.328 0.011 DB12110 | DBMET00379 | |
| 0.504 | 0.032 | 0.561 | Aldehyde oxidase inhibitor | 0.454 0.039 DBMET00379 0.232 0.089 DBMET01712 0.561 0.024 DB12110 | DB12110 | |
| 0.457 | 0.005 | 0.457 | 5 Hydroxytryptamine 1 antagonist | 0.283 0.011 DBMET00379 0.207 0.016 DB12110 | ||
| 0.463 | 0.046 | 0.616 | Antiobesity | 0.616 0.019 DBMET00379 0.226 0.18 DBMET01712 0.487 0.04 DB12110 | DBMET00379 | |
| 0.379 | 0.045 | 0.39 | Spasmolytic | 0.39 0.042 DBMET00379 0.199 0.12 DBMET01712 0.181 0.136 DB12110 | DBMET00379 | |
| 0.364 | 0.036 | 0.364 | Cardiotonic | 0.257 0.078 DBMET01712 | ||
| 0.334 | 0.008 | 0.334 | Alpha 1a adrenoreceptor antagonist | 0.232 0.013 DBMET00379 0.236 0.013 DB12110 | ||
| 0.335 | 0.008 | 0.335 | Antihistaminic | 0.154 0.031 DBMET00379 0.108 0.049 DB12110 | ||
| 0.331 | 0.008 | 0.331 | Histamine antagonist | 0.141 0.032 DBMET00379 0.099 0.048 DB12110 | ||
| 0.329 | 0.007 | 0.329 | Alpha 1b adrenoreceptor antagonist | 0.231 0.012 DBMET00379 0.209 0.014 DB12110 | ||
| 0.314 | 0.011 | 0.314 | Dopamine antagonist | 0.124 0.031 DBMET00379 0.209 0.018 DB12110 | ||
| 0.311 | 0.008 | 0.311 | 5 Hydroxytryptamine 2C antagonist | 0.134 0.031 DBMET00379 0.311 0.008 DB12110 | ||
| 0.307 | 0.006 | 0.307 | 5 Hydroxytryptamine 1 agonist | 0.145 0.015 DBMET00379 0.06 0.033 DBMET01712 0.141 0.015 DB12110 | ||
| 0.304 | 0.014 | 0.304 | 5 Hydroxytryptamine 2B antagonist | 0.172 0.033 DBMET00379 0.298 0.015 DB12110 | ||
| 0.309 | 0.038 | 0.309 | Anticonvulsant | 0.181 0.098 DBMET00379 0.28 0.046 DB12110 | ||
| 0.267 | 0.008 | 0.267 | Histamine H1 receptor antagonist | 0.198 0.015 DBMET00379 0.115 0.034 DB12110 | ||
| 0.251 | 0.009 | 0.251 | Dopamine D4 antagonist | 0.107 0.024 DBMET00379 0.233 0.01 DB12110 | ||
| 0.249 | 0.011 | 0.489 | 5 Hydroxytryptamine agonist | 0.115 0.029 DBMET00379 0.489 0.005 DB12110 | DB12110 | |
| 0.224 | 0.013 | 0.224 | Alpha 2c adrenoreceptor antagonist | 0.205 0.017 DBMET00379 0.224 0.014 DB12110 | ||
| 0.218 | 0.009 | 0.218 | Dopamine D3 antagonist | 0.057 0.048 DBMET00379 0.147 0.015 DB12110 | ||
| 0.21 | 0.011 | 0.384 | 5 Hydroxytryptamine 7 antagonist | 0.117 0.022 DBMET00379 0.384 0.005 DB12110 | DB12110 | |
| 0.202 | 0.017 | 0.202 | Dopamine D2 antagonist | 0.117 0.028 DBMET00379 0.178 0.019 DB12110 | ||
| 0.184 | 0.004 | 0.267 | Peroxisome proliferator-activated receptor delta antagonist | 0.063 0.008 DBMET00379 0.267 0.003 DBMET01712 | DBMET01712 | |
| 0.181 | 0.011 | 0.181 | Alpha 1d adrenoreceptor antagonist | 0.116 0.02 DBMET00379 0.173 0.012 DB12110 | ||
| 0.315 | 0.149 | 0.381 | Cyclophilin D inhibitor | 0.381 0.102 DBMET00379 0.235 0.229 DBMET01712 | DBMET00379 | |
| 0.217 | 0.081 | 0.345 | HERG channel blocker | 0.345 0.039 DB12110 | DB12110 | |
| 0.141 | 0.01 | 0.208 | Alpha 1 adrenoreceptor agonist | 0.17 0.008 DBMET00379 0.208 0.006 DB12110 | DB12110 | |
| 0.146 | 0.023 | 0.246 | Alpha 2a adrenoreceptor antagonist | 0.144 0.024 DBMET00379 0.246 0.009 DB12110 | DB12110 | |
| 0.209 | 0.088 | 0.215 | Hypolipemic | 0.18 0.109 DBMET00379 0.215 0.085 DBMET01712 | DBMET01712 | |
| 0.209 | 0.09 | 0.301 | Potassium channel (Voltage-sensitive) blocker | 0.301 0.049 DB12110 | DB12110 | |
| 0.132 | 0.017 | 0.132 | Phosphodiesterase 6D inhibitor | 0.102 0.048 DBMET00379 0.114 0.03 DBMET01712 | ||
| 0.143 | 0.029 | 0.218 | Alpha 2 adrenoreceptor antagonist | 0.12 0.037 DBMET00379 0.218 0.015 DB12110 | DB12110 | |
| 0.19 | 0.081 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.177 0.114 DBMET01712 0.3 0.005 DB12110 | DB12110 | |
| 0.115 | 0.005 | 0.115 | Dopamine D3 agonist | 0.093 0.008 DBMET00379 0.09 0.008 DB12110 | ||
| 0.148 | 0.04 | 0.29 | Alpha 2b adrenoreceptor antagonist | 0.157 0.036 DBMET00379 0.29 0.01 DB12110 | DB12110 | |
| 0.181 | 0.079 | 0.181 | P-glycoprotein inhibitor | 0.177 0.082 DBMET00379 | ||
| 0.172 | 0.072 | 0.267 | Sigma receptor agonist | 0.126 0.107 DBMET00379 0.267 0.045 DB12110 | DB12110 | |
| 0.195 | 0.098 | 0.251 | Cyclic AMP phosphodiesterase inhibitor | 0.182 0.109 DBMET00379 0.251 0.063 DB12110 | DB12110 | |
| 0.114 | 0.022 | 0.143 | Dopamine agonist | 0.095 0.029 DBMET00379 0.143 0.016 DB12110 | DB12110 | |
| 0.113 | 0.022 | 0.157 | Peroxisome proliferator-activated receptor gamma agonist | 0.069 0.05 DBMET00379 0.157 0.011 DBMET01712 | DBMET01712 | |
| 0.097 | 0.011 | 0.097 | Phosphodiesterase 1C inhibitor | 0.078 0.021 DBMET01712 0.059 0.05 DB12110 | ||
| 0.095 | 0.011 | 0.095 | Dopamine D2 agonist | 0.084 0.013 DBMET00379 0.06 0.021 DB12110 | ||
| 0.107 | 0.023 | 0.112 | Acetylcholine M4 receptor antagonist | 0.112 0.021 DB12110 | DB12110 | |
| 0.093 | 0.01 | 0.093 | Vasopressin 1 antagonist | 0.079 0.011 DBMET00379 0.045 0.016 DBMET01712 | ||
| 0.105 | 0.027 | 0.105 | Cannabinoid receptor antagonist | 0.088 0.035 DB12110 | ||
| 0.099 | 0.027 | 0.278 | 5 Hydroxytryptamine uptake inhibitor | 0.073 0.037 DBMET00379 0.278 0.007 DB12110 | DB12110 | |
| 0.087 | 0.015 | 0.087 | Antidiuretic hormone antagonist | 0.071 0.017 DBMET00379 0.038 0.029 DBMET01712 | ||
| 0.097 | 0.025 | 0.169 | 5 Hydroxytryptamine 1B antagonist | 0.169 0.011 DB12110 | DB12110 | |
| 0.221 | 0.15 | 0.221 | Ca(v)3.3 blocker | |||
| 0.096 | 0.026 | 0.186 | Dopamine D1 antagonist | 0.067 0.042 DBMET00379 0.186 0.011 DB12110 | DB12110 | |
| 0.098 | 0.029 | 0.248 | Alpha adrenoreceptor agonist | 0.126 0.02 DBMET00379 0.248 0.006 DB12110 | DB12110 | |
| 0.092 | 0.026 | 0.092 | Phosphodiesterase VI inhibitor | 0.081 0.039 DBMET01712 | ||
| 0.083 | 0.021 | 0.083 | Phosphodiesterase 1B inhibitor | 0.065 0.036 DBMET01712 | ||
| 0.068 | 0.01 | 0.068 | Vasopressin 1A antagonist | 0.06 0.011 DBMET00379 0.051 0.013 DBMET01712 | ||
| 0.077 | 0.029 | 0.092 | Cannabinoid CB1 receptor antagonist | 0.092 0.019 DB12110 | DB12110 | |
| 0.156 | 0.111 | 0.435 | Psychostimulant | 0.435 0.018 DB12110 | DB12110 | |
| 0.062 | 0.019 | 0.062 | Alpha 1L adrenoreceptor antagonist | 0.056 0.028 DBMET00379 0.052 0.038 DBMET01712 | ||
| 0.05 | 0.01 | 0.075 | Angiotensin AT2 receptor antagonist | 0.075 0.005 DBMET01712 | DBMET01712 | |
| 0.061 | 0.023 | 0.09 | 5 Hydroxytryptamine 4 antagonist | 0.09 0.009 DB12110 | DB12110 | |
| 0.063 | 0.026 | 0.272 | Dopamine D4 agonist | 0.272 0.005 DB12110 | DB12110 | |
| 0.087 | 0.051 | 0.087 | Histamine H2 receptor antagonist | 0.077 0.072 DBMET01712 | ||
| 0.049 | 0.014 | 0.064 | Vasopressin 2 antagonist | 0.064 0.01 DBMET00379 0.046 0.015 DBMET01712 | DBMET00379 | |
| 0.037 | 0.005 | 0.059 | Angiotensin AT1A receptor antagonist | 0.059 0.004 DBMET01712 | DBMET01712 | |
| 0.088 | 0.056 | 0.209 | NMDA receptor antagonist | 0.209 0.013 DB12110 | DB12110 | |
| 0.038 | 0.006 | 0.044 | Vasopressin 1A agonist | 0.037 0.007 DBMET00379 0.044 0.004 DBMET01712 | DBMET01712 | |
| 0.068 | 0.037 | 0.166 | Adrenaline uptake inhibitor | 0.055 0.051 DBMET00379 0.166 0.008 DB12110 | DB12110 | |
| 0.064 | 0.033 | 0.064 | Phosphodiesterase 1A inhibitor | 0.059 0.043 DBMET01712 0.06 0.04 DB12110 | ||
| 0.064 | 0.034 | 0.13 | Dopamine uptake inhibitor | 0.054 0.045 DBMET00379 0.13 0.013 DB12110 | DB12110 | |
| 0.089 | 0.06 | 0.089 | Phosphodiesterase I inhibitor | |||
| 0.039 | 0.014 | 0.039 | CXC chemokine 3 receptor antagonist | |||
| 0.074 | 0.049 | 0.103 | Lipase inhibitor | 0.103 0.026 DBMET01712 | DBMET01712 | |
| 0.054 | 0.029 | 0.093 | Peroxisome proliferator-activated receptor alpha agonist | 0.093 0.014 DBMET01712 | DBMET01712 | |
| 0.065 | 0.044 | 0.136 | 5 Hydroxytryptamine 1D antagonist | 0.136 0.014 DB12110 | DB12110 | |
| 0.209 | 0.191 | 0.297 | Histamine release inhibitor | 0.259 0.149 DBMET00379 0.297 0.125 DB12110 | DB12110 | |
| 0.061 | 0.046 | 0.228 | 5 Hydroxytryptamine 2A agonist | 0.228 0.004 DB12110 | DB12110 | |
| 0.044 | 0.03 | 0.053 | Dopamine D5 antagonist | 0.038 0.034 DBMET00379 0.053 0.023 DB12110 | DB12110 | |
| 0.123 | 0.116 | 0.185 | Neuropeptide Y1 antagonist | 0.185 0.026 DB12110 | DB12110 | |
| 0.026 | 0.02 | 0.027 | Antidiuretic hormone agonist | 0.027 0.02 DBMET01712 | DBMET01712 | |
| 0.101 | 0.095 | 0.101 | Estrogen antagonist | 0.1 0.099 DBMET01712 | ||
| 0.015 | 0.014 | 0.016 | Vasopressin 2 agonist | 0.016 0.013 DBMET01712 | DBMET01712 | |
| 0.02 | 0.019 | 0.023 | Vasopressin 1 agonist | 0.023 0.013 DBMET01712 | DBMET01712 | |
| 0.087 | 0.09 | 0.088 | Estrogen receptor beta antagonist | 0.088 0.087 DBMET01712 | DBMET01712 | |
| 0.045 | 0.05 | 0.065 | Alpha 1b adrenoreceptor agonist | 0.047 0.043 DBMET00379 0.048 0.042 DBMET01712 0.065 0.015 DB12110 | DB12110 | |
| 0.054 | 0.059 | 0.129 | 5 Hydroxytryptamine 5A antagonist | 0.129 0.01 DB12110 | DB12110 | |
| 0.13 | 0.138 | 0.238 | Anesthetic general | 0.238 0.056 DB12110 | DB12110 | |
| 0.252 | 0.265 | 0.565 | Antiinflammatory | 0.565 0.063 DBMET00379 0.564 0.064 DBMET01712 | DBMET00379 | |
| 0.244 | 0.26 | 0.436 | Caspase 9 stimulant | 0.264 0.236 DBMET00379 0.436 0.091 DB12110 | DB12110 | |
| 0.053 | 0.069 | 0.315 | 5 Hydroxytryptamine 1F antagonist | 0.315 0.005 DB12110 | DB12110 | |
| 0.032 | 0.049 | 0.124 | NMDA receptor subunit 3B antagonist | 0.124 0.008 DB12110 | DB12110 | |
| 0.047 | 0.065 | 0.126 | 5 Hydroxytryptamine 5 antagonist | 0.126 0.011 DB12110 | DB12110 | |
| 0.064 | 0.083 | 0.113 | Adrenaline agonist | 0.113 0.029 DBMET00379 0.105 0.034 DB12110 | DBMET00379 | |
| 0.009 | 0.029 | 0.024 | Peroxisome proliferator-activated receptor alpha antagonist | 0.024 0.014 DBMET01712 | DBMET01712 | |
| 0.025 | 0.051 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 DB12110 | DB12110 | |
| 0.035 | 0.063 | 0.07 | Melanin-concentrating hormone receptor 1 antagonist | 0.07 0.024 DB12110 | DB12110 | |
| 0.046 | 0.075 | 0.109 | Acetylcholine M5 receptor agonist | 0.109 0.015 DB12110 | DB12110 | |
| 0.011 | 0.044 | 0.032 | Dopamine autoreceptor agonist | 0.032 0.012 DB12110 | DB12110 | |
| 0.058 | 0.092 | 0.115 | MDM2 inhibitor | 0.115 0.004 DB12110 | DB12110 | |
| 0.024 | 0.06 | 0.057 | p53 inhibitor | 0.057 0.01 DB12110 | DB12110 | |
| 0.027 | 0.065 | 0.054 | Angiotensin AT1 receptor antagonist | 0.054 0.013 DBMET01712 | DBMET01712 | |
| 0.025 | 0.064 | 0.057 | Somatostatin 4 agonist | 0.057 0.013 DB12110 | DB12110 | |
| 0.074 | 0.117 | 0.324 | 5 Hydroxytryptamine 3A agonist | 0.324 0.003 DB12110 | DB12110 | |
| 0.02 | 0.066 | 0.082 | NMDA receptor subunit 3A antagonist | 0.082 0.011 DB12110 | DB12110 | |
| 0.077 | 0.126 | 0.114 | Acetylcholine muscarinic antagonist | 0.114 0.074 DB12110 | DB12110 | |
| 0.022 | 0.072 | 0.05 | Protein kinase C beta II inhibitor | 0.05 0.006 DBMET01712 0.031 0.025 DB12110 | DBMET01712 | |
| 0.021 | 0.073 | 0.044 | Angiotensin II receptor antagonist | 0.044 0.01 DBMET01712 | DBMET01712 | |
| 0.22 | 0.273 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.269 0.202 DBMET00379 0.48 0.039 DB12110 | DB12110 | |
| 0.016 | 0.07 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 DB12110 | DB12110 | |
| 0.065 | 0.121 | 0.087 | Interleukin 5 antagonist | 0.087 0.059 DBMET00379 | DBMET00379 | |
| 0.085 | 0.143 | 0.259 | Toll-Like receptor 9 antagonist | 0.259 0.019 DB12110 | DB12110 | |
| 0.142 | 0.203 | 0.346 | 5 Hydroxytryptamine 1E antagonist | 0.346 0.011 DB12110 | DB12110 | |
| 0.09 | 0.151 | 0.141 | Antibacterial (Helicobacter pylori) | 0.141 0.055 DB12110 | DB12110 | |
| 0.026 | 0.089 | 0.066 | Dopamine transporter inhibitor | 0.066 0.022 DB12110 | DB12110 | |
| 0.018 | 0.086 | 0.076 | Vascular adhesion protein 1 inhibitor | 0.076 0.005 DB12110 | DB12110 | |
| 0.01 | 0.078 | 0.03 | CC chemokine 1 receptor antagonist | 0.03 0.013 DB12110 | DB12110 | |
| 0.065 | 0.134 | 0.171 | Lanosterol 14 alpha demethylase inhibitor | 0.105 0.049 DBMET00379 0.171 0.007 DB12110 | DB12110 | |
| 0.031 | 0.102 | 0.173 | 5 Hydroxytryptamine 6 antagonist | 0.173 0.005 DB12110 | DB12110 | |
| 0.033 | 0.107 | 0.05 | Heme oxygenase inhibitor | 0.05 0.013 DB12110 | DB12110 | |
| 0.07 | 0.146 | 0.124 | Acetylcholine antagonist | 0.124 0.067 DB12110 | DB12110 | |
| 0.031 | 0.109 | 0.085 | Acetylcholine M5 receptor antagonist | 0.085 0.022 DB12110 | DB12110 | |
| 0.071 | 0.15 | 0.127 | Cholinergic antagonist | 0.127 0.068 DB12110 | DB12110 | |
| 0.063 | 0.143 | 0.081 | Ca(v)3.1 blocker | 0.081 0.057 DB12110 | DB12110 | |
| 0.042 | 0.122 | 0.109 | Bcl2 antagonist | 0.109 0.014 DB12110 | DB12110 | |
| 0.082 | 0.165 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 DB12110 | DB12110 | |
| 0.009 | 0.092 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 DB12110 | DB12110 | |
| 0.038 | 0.122 | 0.091 | Heat shock protein 90 beta antagonist | 0.091 0.014 DB12110 | DB12110 | |
| 0.014 | 0.103 | 0.037 | Purinergic P2X7 antagonist | 0.037 0.024 DB12110 | DB12110 | |
| 0.031 | 0.125 | 0.1 | Calcium channel T-type blocker | 0.1 0.016 DB12110 | DB12110 | |
| 0.031 | 0.128 | 0.06 | Parathyroid hormone antagonist | 0.06 0.011 DB12110 | DB12110 | |
| 0.164 | 0.262 | 0.583 | GABA C receptor rho-3 antagonist | 0.208 0.198 DBMET01712 0.583 0.009 DB12110 | DB12110 | |
| 0.074 | 0.175 | 0.184 | Nav1.2 sodium channel blocker | 0.184 0.04 DB12110 | DB12110 | |
| 0.168 | 0.269 | 0.461 | Calcium channel activator | 0.233 0.168 DBMET00379 0.461 0.009 DB12110 | DB12110 | |
| 0.127 | 0.232 | 0.488 | Superoxide dismutase inhibitor | 0.17 0.155 DBMET01712 0.488 0.014 DB12110 | DB12110 | |
| 0.016 | 0.124 | 0.044 | Estrogen-related receptor gamma antagonist | 0.044 0.004 DB12110 | DB12110 | |
| 0.025 | 0.135 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.032 DB12110 | DB12110 | |
| 0.02 | 0.131 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 DB12110 | DB12110 | |
| 0.029 | 0.143 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 DB12110 | DB12110 | |
| 0.052 | 0.168 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 DB12110 | DB12110 | |
| 0.131 | 0.248 | 0.256 | ErbB-1 antagonist | 0.256 0.049 DB12110 | DB12110 | |
| 0.14 | 0.257 | 0.268 | Vasodilator, coronary | 0.268 0.117 DB12110 | DB12110 | |
| 0.029 | 0.15 | 0.087 | CC chemokine receptor 2B antagonist | 0.087 0.007 DB12110 | DB12110 | |
| 0.078 | 0.2 | 0.135 | Diuretic | 0.135 0.09 DB12110 | DB12110 | |
| 0.047 | 0.174 | 0.089 | Sphingomyelinase inhibitor | 0.089 0.074 DB12110 | DB12110 | |
| 0.09 | 0.218 | 0.171 | Potassium channel blocker | 0.171 0.115 DB12110 | DB12110 | |
| 0.025 | 0.16 | 0.157 | 5 Hydroxytryptamine 3A antagonist | 0.157 0.005 DB12110 | DB12110 | |
| 0.019 | 0.154 | 0.058 | Purinergic P2X antagonist | 0.058 0.025 DB12110 | DB12110 | |
| 0.022 | 0.16 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 DB12110 | DB12110 | |
| 0.046 | 0.184 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 DB12110 | DB12110 | |
| 0.026 | 0.166 | 0.117 | Benzodiazepine agonist | 0.117 0.017 DB12110 | DB12110 | |
| 0.126 | 0.269 | 0.275 | Cholesterol antagonist | 0.275 0.108 DB12110 | DB12110 | |
| 0.009 | 0.155 | 0.097 | 5 Hydroxytryptamine 3B antagonist | 0.097 0.005 DB12110 | DB12110 | |
| 0.021 | 0.166 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.06 0.036 DB12110 | DB12110 | |
| 0.031 | 0.177 | 0.156 | Phospholipase D inhibitor | 0.156 0.003 DB12110 | DB12110 | |
| 0.014 | 0.162 | 0.07 | Acetylcholine muscarinic agonist | 0.07 0.027 DB12110 | DB12110 | |
| 0.016 | 0.165 | 0.063 | Bromodomain-containing protein 3 inhibitor | 0.063 0.017 DB12110 | DB12110 | |
| 0.052 | 0.203 | 0.138 | Nav1.3 sodium channel blocker | 0.138 0.056 DB12110 | DB12110 | |
| 0.091 | 0.25 | 0.286 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 DB12110 | DB12110 | |
| 0.077 | 0.237 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 DB12110 | DB12110 | |
| 0.021 | 0.182 | 0.065 | Purinergic P2 antagonist | 0.065 0.043 DB12110 | DB12110 | |
| 0.005 | 0.167 | 0.026 | Urotensin II antagonist | 0.026 0.012 DB12110 | DB12110 | |
| 0.104 | 0.271 | 0.175 | Catenin beta inhibitor | 0.175 0.059 DB12110 | DB12110 | |
| 0.019 | 0.187 | 0.238 | 5 Hydroxytryptamine 3 antagonist | 0.238 0.005 DB12110 | DB12110 | |
| 0.027 | 0.196 | 0.153 | 5 Hydroxytryptamine 7 agonist | 0.153 0.004 DB12110 | DB12110 | |
| 0.063 | 0.241 | 0.195 | Acetylcholine M1 receptor antagonist | 0.195 0.045 DB12110 | DB12110 | |
| 0.023 | 0.201 | 0.105 | Toll-Like receptor 7 antagonist | 0.105 0.018 DB12110 | DB12110 | |
| 0.02 | 0.197 | 0.103 | Histamine agonist | 0.103 0.009 DB12110 | DB12110 | |
| 0.201 | 0.379 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.477 0.045 DB12110 | DB12110 | |
| 0.047 | 0.227 | 0.17 | Bromodomain-containing protein 2 inhibitor | 0.17 0.005 DB12110 | DB12110 | |
| 0.059 | 0.242 | 0.111 | Calcium channel blocker | 0.111 0.098 DB12110 | DB12110 | |
| 0.008 | 0.193 | 0.057 | Acetylcholine M1 receptor agonist | 0.057 0.023 DB12110 | DB12110 | |
| 0.046 | 0.237 | 0.14 | Phosphodiesterase 7B inhibitor | 0.14 0.025 DB12110 | DB12110 | |
| 0.044 | 0.235 | 0.207 | Protein kinase C zeta inhibitor | 0.207 0.01 DB12110 | DB12110 | |
| 0.055 | 0.248 | 0.085 | Transforming growth factor beta 3 antagonist | 0.085 0.049 DB12110 | DB12110 | |
| 0.029 | 0.225 | 0.124 | Corticotropin releasing factor 2 receptor antagonist | 0.124 0.004 DB12110 | DB12110 | |
| 0.026 | 0.225 | 0.224 | 5 Hydroxytryptamine 3 agonist | 0.224 0.003 DB12110 | DB12110 | |
| 0.022 | 0.221 | 0.083 | CXC chemokine receptor antagonist | 0.083 0.034 DB12110 | DB12110 | |
| 0.025 | 0.226 | 0.191 | Cyclin B3 inhibitor | 0.191 0.007 DB12110 | DB12110 | |
| 0.009 | 0.212 | 0.04 | Acid ceramidase inhibitor | 0.04 0.004 DB12110 | DB12110 | |
| 0.021 | 0.224 | 0.101 | Cyclin D1 inhibitor | 0.101 0.008 DB12110 | DB12110 | |
| 0.038 | 0.243 | 0.2 | Glutamate receptor antagonist | 0.2 0.025 DB12110 | DB12110 | |
| 0.023 | 0.23 | 0.09 | Alpha 1L adrenoreceptor agonist | 0.09 0.003 DB12110 | DB12110 | |
| 0.051 | 0.261 | 0.23 | Activin receptor-like kinase 2 inhibitor | 0.23 0.026 DB12110 | DB12110 | |
| 0.157 | 0.37 | 0.323 | MAP kinase kinase 6 inhibitor | 0.323 0.114 DB12110 | DB12110 | |
| 0.033 | 0.246 | 0.115 | Urease inhibitor | 0.115 0.05 DB12110 | DB12110 | |
| 0.026 | 0.24 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.029 DB12110 | DB12110 | |
| 0.028 | 0.244 | 0.063 | Ca(v)3.2 blocker | 0.063 0.033 DB12110 | DB12110 | |
| 0.027 | 0.245 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 DB12110 | DB12110 | |
| 0.009 | 0.232 | 0.235 | 5 Hydroxytryptamine 2 agonist | 0.235 0.004 DB12110 | DB12110 | |
| 0.007 | 0.231 | 0.055 | Glycine transporter inhibitor | 0.055 0.028 DB12110 | DB12110 | |
| 0.034 | 0.259 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 DB12110 | DB12110 | |
| 0.007 | 0.234 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.018 DB12110 | DB12110 | |
| 0.044 | 0.272 | 0.098 | Calcium channel (voltage-sensitive) blocker | 0.098 0.086 DB12110 | DB12110 | |
| 0.013 | 0.243 | 0.027 | Complement factor 1r inhibitor | 0.027 0.015 DB12110 | DB12110 | |
| 0.029 | 0.259 | 0.17 | Histamine N-methyltransferase inhibitor | 0.17 0.009 DB12110 | DB12110 | |
| 0.04 | 0.271 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.227 0.027 DB12110 | DB12110 | |
| 0.016 | 0.249 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.027 DB12110 | DB12110 | |
| 0.087 | 0.323 | 0.18 | Thyroid hormone beta antagonist | 0.18 0.174 DB12110 | DB12110 | |
| 0.05 | 0.289 | 0.234 | Toll-Like receptor antagonist | 0.234 0.02 DB12110 | DB12110 | |
| 0.034 | 0.274 | 0.136 | Cystathionine beta-synthase inhibitor | 0.136 0.047 DB12110 | DB12110 | |
| 0.035 | 0.276 | 0.111 | Insulin receptor antagonist | 0.111 0.05 DB12110 | DB12110 | |
| 0.024 | 0.268 | 0.152 | Acetylcholine agonist | 0.152 0.025 DB12110 | DB12110 | |
| 0.012 | 0.257 | 0.075 | Nerve growth factor antagonist | 0.075 0.004 DB12110 | DB12110 | |
| 0.008 | 0.258 | 0.063 | Cyclin D3 inhibitor | 0.063 0.016 DB12110 | DB12110 | |
| 0.065 | 0.316 | 0.15 | Polo-like kinase-3 inhibitor | 0.15 0.084 DB12110 | DB12110 | |
| 0.005 | 0.256 | 0.035 | Cyclin E2 inhibitor | 0.035 0.015 DB12110 | DB12110 | |
| 0.021 | 0.275 | 0.048 | CF transmembrane conductance regulator antagonist | 0.048 0.01 DB12110 | DB12110 | |
| 0.015 | 0.269 | 0.072 | Amidase inhibitor | 0.072 0.045 DB12110 | DB12110 | |
| 0.006 | 0.263 | 0.322 | 5 Hydroxytryptamine 2C agonist | 0.322 0.003 DB12110 | DB12110 | |
| 0.036 | 0.293 | 0.144 | GABA receptor agonist | 0.144 0.039 DB12110 | DB12110 | |
| 0.005 | 0.264 | 0.02 | Cyclin D2 inhibitor | 0.02 0.004 DB12110 | DB12110 | |
| 0.024 | 0.283 | 0.192 | ALK inhibitor | 0.192 0.012 DB12110 | DB12110 | |
| 0.012 | 0.272 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 DB12110 | DB12110 | |
| 0.091 | 0.354 | 0.307 | MAP-kinase-activated kinase 5 inhibitor | 0.307 0.026 DB12110 | DB12110 | |
| 0.005 | 0.272 | 0.07 | Methionyl aminopeptidase 1 inhibitor | 0.07 0.004 DB12110 | DB12110 | |
| 0.01 | 0.279 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 DB12110 | DB12110 | |
| 0.103 | 0.374 | 0.329 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.329 0.046 DB12110 | DB12110 | |
| 0.098 | 0.372 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.149 0.045 DB12110 | DB12110 | |
| 0.017 | 0.291 | 0.136 | Acetylcholine nicotinic antagonist | 0.136 0.025 DB12110 | DB12110 | |
| 0.022 | 0.299 | 0.113 | Chemokine receptor antagonist | 0.113 0.053 DB12110 | DB12110 | |
| 0.021 | 0.299 | 0.112 | Calcium antagonist | 0.112 0.039 DB12110 | DB12110 | |
| 0.036 | 0.316 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 DB12110 | DB12110 | |
| 0.014 | 0.296 | 0.123 | Neuronal nicotinic receptor antagonist | 0.123 0.017 DB12110 | DB12110 | |
| 0.06 | 0.345 | 0.223 | GABA C receptor rho-2 antagonist | 0.223 0.019 DB12110 | DB12110 | |
| 0.059 | 0.348 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 DB12110 | DB12110 | |
| 0.11 | 0.399 | 0.279 | Analgesic | 0.279 0.159 DB12110 | DB12110 | |
| 0.008 | 0.299 | 0.084 | NMDA 2A receptor antagonist | 0.084 0.018 DB12110 | DB12110 | |
| 0.005 | 0.296 | 0.108 | Potassium channel small-conductance Ca-activated activator | 0.108 0.004 DB12110 | DB12110 | |
| 0.012 | 0.305 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DB12110 | DB12110 | |
| 0.012 | 0.309 | 0.205 | 5 Hydroxytryptamine 2B agonist | 0.205 0.002 DB12110 | DB12110 | |
| 0.022 | 0.32 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.073 DB12110 | DB12110 | |
| 0.013 | 0.316 | 0.175 | Nicotinic alpha4beta2 receptor antagonist | 0.175 0.005 DB12110 | DB12110 | |
| 0.043 | 0.349 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 DB12110 | DB12110 | |
| 0.004 | 0.311 | 0.065 | Kainate receptor 2 antagonist | 0.065 0.01 DB12110 | DB12110 | |
| 0.006 | 0.317 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 DB12110 | DB12110 | |
| 0.032 | 0.347 | 0.114 | Nav1.6 sodium channel blocker | 0.114 0.105 DB12110 | DB12110 | |
| 0.014 | 0.33 | 0.069 | CC chemokine receptor antagonist | 0.069 0.064 DB12110 | DB12110 | |
| 0.01 | 0.326 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 DB12110 | DB12110 | |
| 0.04 | 0.357 | 0.146 | Hedgehog signaling inhibitor | 0.146 0.025 DB12110 | DB12110 | |
| 0.055 | 0.371 | 0.147 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.147 0.132 DB12110 | DB12110 | |
| 0.01 | 0.33 | 0.076 | GABA receptor antagonist | 0.076 0.023 DB12110 | DB12110 | |
| 0.048 | 0.368 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 DB12110 | DB12110 | |
| 0.066 | 0.388 | 0.239 | Calpain 2 inhibitor | 0.239 0.157 DB12110 | DB12110 | |
| 0.024 | 0.349 | 0.09 | EphA2 antagonist | 0.09 0.087 DB12110 | DB12110 | |
| 0.079 | 0.404 | 0.194 | Antithrombotic | 0.194 0.185 DB12110 | DB12110 | |
| 0.014 | 0.34 | 0.13 | Histamine H4 receptor antagonist | 0.13 0.004 DB12110 | DB12110 | |
| 0.012 | 0.34 | 0.036 | Vanilloid 4 antagonist | 0.036 0.016 DB12110 | DB12110 | |
| 0.005 | 0.333 | 0.17 | NMDA 2 receptor antagonist | 0.17 0.013 DB12110 | DB12110 | |
| 0.014 | 0.344 | 0.092 | Protein kinase C beta inhibitor | 0.092 0.018 DB12110 | DB12110 | |
| 0.004 | 0.335 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.01 DB12110 | DB12110 | |
| 0.038 | 0.371 | 0.1 | Alpha 2d adrenoreceptor antagonist | 0.1 0.049 DB12110 | DB12110 | |
| 0.036 | 0.37 | 0.119 | Nav1.5 sodium channel blocker | 0.119 0.055 DB12110 | DB12110 | |
| 0.045 | 0.379 | 0.097 | T cell inhibitor | 0.097 0.028 DB12110 | DB12110 | |
| 0.007 | 0.341 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DB12110 | DB12110 | |
| 0.005 | 0.339 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 DB12110 | DB12110 | |
| 0.015 | 0.35 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.027 DB12110 | DB12110 | |
| 0.015 | 0.35 | 0.089 | Protein kinase C alpha inhibitor | 0.089 0.028 DB12110 | DB12110 | |
| 0.082 | 0.419 | 0.713 | 5 Hydroxytryptamine release stimulant | 0.713 0.006 DB12110 | DB12110 | |
| 0.016 | 0.354 | 0.065 | Potassium channel small-conductance Ca-activated blocker | 0.065 0.015 DB12110 | DB12110 | |
| 0.063 | 0.401 | 0.189 | Neurotrophic factor enhancer | 0.189 0.088 DB12110 | DB12110 | |
| 0.015 | 0.355 | 0.099 | Insulin like growth factor 1 antagonist | 0.099 0.042 DB12110 | DB12110 | |
| 0.072 | 0.413 | 0.153 | Death-associated protein kinase 1 inhibitor | 0.153 0.035 DB12110 | DB12110 | |
| 0.005 | 0.346 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 DB12110 | DB12110 | |
| 0.054 | 0.399 | 0.172 | Factor V inhibitor | 0.172 0.011 DBMET01712 | DBMET01712 | |
| 0.003 | 0.348 | 0.052 | Histamine H4 receptor agonist | 0.052 0.004 DB12110 | DB12110 | |
| 0.023 | 0.369 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 DB12110 | DB12110 | |
| 0.068 | 0.414 | 0.138 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.083 DB12110 | DB12110 | |
| 0.014 | 0.366 | 0.106 | Insulin growth factor antagonist | 0.106 0.043 DB12110 | DB12110 | |
| 0.004 | 0.359 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.033 0.026 DB12110 | DB12110 | |
| 0.003 | 0.357 | 0.025 | 5 Hydroxytryptamine 1D agonist | 0.025 0.023 DB12110 | DB12110 | |
| 0.01 | 0.368 | 0.06 | EphB4 antagonist | 0.06 0.038 DB12110 | DB12110 | |
| 0.022 | 0.384 | 0.09 | Myeloperoxidase inhibitor | 0.09 0.049 DB12110 | DB12110 | |
| 0.037 | 0.4 | 0.342 | NADPH oxidase inhibitor | 0.342 0.008 DB12110 | DB12110 | |
| 0.003 | 0.367 | 0.019 | Complement factor D inhibitor | 0.019 0.011 DB12110 | DB12110 | |
| 0.036 | 0.4 | 0.152 | Activin receptor-like kinase 4 inhibitor | 0.152 0.028 DB12110 | DB12110 | |
| 0.005 | 0.371 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.028 DB12110 | DB12110 | |
| 0.005 | 0.373 | 0.03 | Calcium-sensing receptor agonist | 0.03 0.013 DB12110 | DB12110 | |
| 0.018 | 0.387 | 0.101 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.101 0.01 DB12110 | DB12110 | |
| 0.045 | 0.415 | 0.113 | Glutamate release inhibitor | 0.113 0.027 DB12110 | DB12110 | |
| 0.007 | 0.381 | 0.109 | Toll-Like receptor 8 antagonist | 0.109 0.007 DB12110 | DB12110 | |
| 0.037 | 0.414 | 0.132 | Arachidonic acid antagonist | 0.132 0.11 DB12110 | DB12110 | |
| 0.014 | 0.398 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 DB12110 | DB12110 | |
| 0.035 | 0.421 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.035 DB12110 | DB12110 | |
| 0.012 | 0.398 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 DB12110 | DB12110 | |
| 0.02 | 0.407 | 0.099 | Caspase 7 inhibitor | 0.099 0.029 DB12110 | DB12110 | |
| 0.02 | 0.409 | 0.097 | Polo-like kinase-1 inhibitor | 0.097 0.049 DB12110 | DB12110 | |
| 0.036 | 0.426 | 0.155 | Cyclooxygenase 3 inhibitor | 0.155 0.044 DB12110 | DB12110 | |
| 0.02 | 0.411 | 0.076 | GABA A receptor agonist | 0.076 0.07 DB12110 | DB12110 | |
| 0.004 | 0.397 | 0.032 | Myristoyl transferase inhibitor | 0.032 0.011 DB12110 | DB12110 | |
| 0.024 | 0.419 | 0.072 | Viral attachment inhibitor | 0.072 0.069 DB12110 | DB12110 | |
| 0.008 | 0.405 | 0.071 | Phosphodiesterase VII inhibitor | 0.071 0.034 DB12110 | DB12110 | |
| 0.03 | 0.426 | 0.115 | Amylase inhibitor | 0.115 0.084 DB12110 | DB12110 | |
| 0.008 | 0.405 | 0.061 | Histamine H1 receptor agonist | 0.061 0.008 DB12110 | DB12110 | |
| 0.018 | 0.416 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | 0.085 0.011 DB12110 | DB12110 | |
| 0.01 | 0.41 | 0.069 | GABA B receptor antagonist | 0.069 0.009 DB12110 | DB12110 | |
| 0.028 | 0.429 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.153 0.026 DB12110 | DB12110 | |
| 0.032 | 0.434 | 0.142 | Mannose-6-phosphate isomerase inhibitor | 0.142 0.072 DB12110 | DB12110 | |
| 0.03 | 0.433 | 0.141 | NADH dehydrogenase inhibitor | 0.141 0.02 DB12110 | DB12110 | |
| 0.002 | 0.406 | 0.019 | Integrin beta2 antagonist | 0.019 0.005 DB12110 | DB12110 | |
| 0.008 | 0.416 | 0.078 | CDK4/cyclin D1 inhibitor | 0.078 0.025 DB12110 | DB12110 | |
| 0.011 | 0.419 | 0.049 | Transforming growth factor beta 1 antagonist | 0.049 0.035 DB12110 | DB12110 | |
| 0.07 | 0.481 | 0.334 | Vasodilator, peripheral | 0.334 0.081 DB12110 | DB12110 | |
| 0.024 | 0.437 | 0.111 | GABA B receptor agonist | 0.111 0.01 DB12110 | DB12110 | |
| 0.009 | 0.423 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | 0.042 0.036 DB12110 | DB12110 | |
| 0.027 | 0.442 | 0.171 | Electrolyte absorption antagonist | 0.171 0.013 DB12110 | DB12110 | |
| 0.005 | 0.433 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 DB12110 | DB12110 | |
| 0.066 | 0.496 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 DB12110 | DB12110 | |
| 0.019 | 0.449 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 DB12110 | DB12110 | |
| 0.002 | 0.433 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.019 DB12110 | DB12110 | |
| 0.009 | 0.441 | 0.107 | Cyclin-dependent kinase 4 inhibitor | 0.107 0.024 DB12110 | DB12110 | |
| 0.007 | 0.442 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | 0.061 0.019 DB12110 | DB12110 | |
| 0.008 | 0.443 | 0.077 | Cyclin B1 inhibitor | 0.077 0.025 DB12110 | DB12110 | |
| 0.007 | 0.448 | 0.065 | Cyclin B2 inhibitor | 0.065 0.027 DB12110 | DB12110 | |
| 0.011 | 0.452 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 DB12110 | DB12110 | |
| 0.011 | 0.452 | 0.051 | Myc inhibitor | 0.051 0.043 DB12110 | DB12110 | |
| 0.022 | 0.463 | 0.091 | Exportin-1 inhibitor | 0.091 0.014 DB12110 | DB12110 | |
| 0.016 | 0.457 | 0.068 | Cyclin H inhibitor | 0.068 0.03 DB12110 | DB12110 | |
| 0.011 | 0.453 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DB12110 | DB12110 | |
| 0.002 | 0.445 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 DB12110 | DB12110 | |
| 0.016 | 0.466 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DB12110 | DB12110 | |
| 0.004 | 0.454 | 0.05 | AMPA receptor antagonist | 0.05 0.031 DB12110 | DB12110 | |
| 0.039 | 0.49 | 0.329 | Interleukin agonist | 0.329 0.036 DB12110 | DB12110 | |
| 0.008 | 0.462 | 0.064 | CDK4/cyclin D inhibitor | 0.064 0.033 DB12110 | DB12110 | |
| 0.004 | 0.459 | 0.044 | LFA antagonist | 0.044 0.007 DB12110 | DB12110 | |
| 0.006 | 0.463 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 DB12110 | DB12110 | |
| 0.082 | 0.542 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.279 0.045 DB12110 | DB12110 | |
| 0.035 | 0.497 | 0.197 | Succinate dehydrogenase inhibitor | 0.197 0.051 DB12110 | DB12110 | |
| 0.007 | 0.469 | 0.065 | Cyclin B inhibitor | 0.065 0.026 DB12110 | DB12110 | |
| 0.005 | 0.469 | 0.055 | Glutamate (mGluR5) agonist | 0.055 0.021 DB12110 | DB12110 | |
| 0.011 | 0.479 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 DB12110 | DB12110 | |
| 0.037 | 0.51 | 0.153 | Antipruritic | 0.153 0.091 DB12110 | DB12110 | |
| 0.011 | 0.485 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 DB12110 | DB12110 | |
| 0.008 | 0.483 | 0.087 | Check point kinase 1 inhibitor | 0.087 0.034 DB12110 | DB12110 | |
| 0.011 | 0.488 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.016 DB12110 | DB12110 | |
| 0.038 | 0.516 | 0.171 | Transcription factor STAT6 inhibitor | 0.171 0.013 DB12110 | DB12110 | |
| 0.011 | 0.489 | 0.053 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 DB12110 | DB12110 | |
| 0.004 | 0.487 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DB12110 | DB12110 | |
| 0.033 | 0.516 | 0.179 | DNA methylase inhibitor | 0.179 0.094 DB12110 | DB12110 | |
| 0.019 | 0.507 | 0.152 | AMP-activated protein kinase stimulant | 0.152 0.027 DB12110 | DB12110 | |
| 0.007 | 0.496 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 DB12110 | DB12110 | |
| 0.003 | 0.492 | 0.055 | Kainate receptor antagonist | 0.055 0.019 DB12110 | DB12110 | |
| 0.046 | 0.537 | 0.268 | Neuropeptide Y2 antagonist | 0.268 0.04 DB12110 | DB12110 | |
| 0.008 | 0.506 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DB12110 | DB12110 | |
| 0.028 | 0.525 | 0.143 | DNA methyltransferase I inhibitor | 0.143 0.111 DB12110 | DB12110 | |
| 0.001 | 0.501 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 DB12110 | DB12110 | |
| 0.037 | 0.54 | 0.189 | DNA damaging | 0.189 0.125 DB12110 | DB12110 | |
| 0.004 | 0.508 | 0.053 | Glutamate (mGluR group I) agonist | 0.053 0.028 DB12110 | DB12110 | |
| 0.048 | 0.551 | 0.165 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.165 0.125 DB12110 | DB12110 | |
| 0.04 | 0.545 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 DB12110 | DB12110 | |
| 0.011 | 0.518 | 0.154 | Purinergic P2X4 antagonist | 0.154 0.004 DB12110 | DB12110 | |
| 0.018 | 0.526 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 DB12110 | DB12110 | |
| 0.005 | 0.517 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 DB12110 | DB12110 | |
| 0.005 | 0.517 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 DB12110 | DB12110 | |
| 0.013 | 0.526 | 0.092 | Falcipain 3 inhibitor | 0.092 0.079 DB12110 | DB12110 | |
| 0.001 | 0.515 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 DB12110 | DB12110 | |
| 0.036 | 0.551 | 0.197 | ATPase inhibitor | 0.197 0.04 DB12110 | DB12110 | |
| 0.005 | 0.524 | 0.11 | Nicotinic neuronal receptor agonist | 0.11 0.01 DB12110 | DB12110 | |
| 0.021 | 0.542 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.077 DB12110 | DB12110 | |
| 0.018 | 0.541 | 0.17 | GABA C receptor rho-1 antagonist | 0.17 0.014 DB12110 | DB12110 | |
| 0.006 | 0.529 | 0.06 | Androgen agonist | 0.06 0.041 DB12110 | DB12110 | |
| 0.006 | 0.531 | 0.059 | Nicotinic alpha7 receptor agonist | 0.059 0.032 DB12110 | DB12110 | |
| 0.033 | 0.558 | 0.154 | Adenylate cyclase stimulant | 0.154 0.056 DB12110 | DB12110 | |
| 0.046 | 0.572 | 0.226 | Gastrin inhibitor | 0.226 0.11 DB12110 | DB12110 | |
| 0.104 | 0.635 | 0.226 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.226 0.103 DB12110 | DB12110 | |
| 0.02 | 0.552 | 0.128 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 DB12110 | DB12110 | |
| 0.016 | 0.548 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 DB12110 | DB12110 | |
| 0.013 | 0.547 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 DB12110 | DB12110 | |
| 0.002 | 0.54 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DB12110 | DB12110 | |
| 0.01 | 0.548 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.063 DB12110 | DB12110 | |
| 0.006 | 0.545 | 0.093 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.093 0.04 DB12110 | DB12110 | |
| 0.028 | 0.568 | 0.129 | Thiol protease inhibitor | 0.129 0.099 DB12110 | DB12110 | |
| 0.002 | 0.542 | 0.092 | Nicotinic alpha4 receptor agonist | 0.092 0.003 DB12110 | DB12110 | |
| 0.016 | 0.557 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 DB12110 | DB12110 | |
| 0.006 | 0.549 | 0.168 | Acetylcholine nicotinic agonist | 0.168 0.012 DB12110 | DB12110 | |
| 0.011 | 0.554 | 0.103 | Protein kinase C delta inhibitor | 0.103 0.05 DB12110 | DB12110 | |
| 0.006 | 0.553 | 0.065 | CC chemokine 2 receptor antagonist | 0.065 0.028 DB12110 | DB12110 | |
| 0.012 | 0.56 | 0.114 | Sodium channel blocker | 0.114 0.092 DB12110 | DB12110 | |
| 0.004 | 0.555 | 0.024 | Geranylgeranyltransferase inhibitor | 0.024 0.013 DB12110 | DB12110 | |
| 0.002 | 0.554 | 0.054 | Imidazoline I1 receptor antagonist | 0.054 0.004 DB12110 | DB12110 | |
| 0.003 | 0.561 | 0.048 | 5 Hydroxytryptamine 6 agonist | 0.048 0.005 DB12110 | DB12110 | |
| 0.009 | 0.568 | 0.085 | NMDA receptor agonist | 0.085 0.026 DB12110 | DB12110 | |
| 0.035 | 0.595 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 DB12110 | DB12110 | |
| 0.011 | 0.576 | 0.056 | MAP kinase kinase 9 inhibitor | 0.056 0.038 DB12110 | DB12110 | |
| 0.014 | 0.58 | 0.077 | Neuropeptide Y antagonist | 0.077 0.063 DB12110 | DB12110 | |
| 0.01 | 0.577 | 0.164 | Glycine receptor antagonist | 0.164 0.005 DB12110 | DB12110 | |
| 0.008 | 0.576 | 0.065 | CDK1/cyclin B1 inhibitor | 0.065 0.054 DB12110 | DB12110 | |
| 0.027 | 0.596 | 0.222 | Focal adhesion kinase 2 inhibitor | 0.222 0.053 DB12110 | DB12110 | |
| 0.035 | 0.605 | 0.162 | CF transmembrane conductance regulator agonist | 0.162 0.057 DB12110 | DB12110 | |
| 0.074 | 0.643 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 DB12110 | DB12110 | |
| 0.02 | 0.591 | 0.102 | Vanilloid 4 agonist | 0.102 0.015 DB12110 | DB12110 | |
| 0.005 | 0.576 | 0.036 | Melanocortin 1 antagonist | 0.036 0.029 DB12110 | DB12110 | |
| 0.039 | 0.611 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.074 DB12110 | DB12110 | |
| 0.031 | 0.606 | 0.231 | Phospholipase C inhibitor | 0.231 0.029 DB12110 | DB12110 | |
| 0.013 | 0.591 | 0.134 | MAP-kinase-activated kinase inhibitor | 0.134 0.02 DB12110 | DB12110 | |
| 0.01 | 0.589 | 0.12 | MAP-kinase-activated kinase 2 inhibitor | 0.12 0.02 DB12110 | DB12110 | |
| 0.016 | 0.594 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 DB12110 | DB12110 | |
| 0.019 | 0.599 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.087 DB12110 | DB12110 | |
| 0.003 | 0.584 | 0.043 | Diamine oxidase inhibitor | 0.043 0.02 DB12110 | DB12110 | |
| 0.018 | 0.601 | 0.147 | Interleukin 8 antagonist | 0.147 0.036 DB12110 | DB12110 | |
| 0.005 | 0.59 | 0.02 | Factor XIII inhibitor | 0.02 0.017 DB12110 | DB12110 | |
| 0.01 | 0.596 | 0.093 | MAP kinase kinase 1 inhibitor | 0.093 0.066 DB12110 | DB12110 | |
| 0.042 | 0.629 | 0.21 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 DB12110 | DB12110 | |
| 0.022 | 0.611 | 0.183 | Pregnane X receptor agonist | 0.183 0.017 DB12110 | DB12110 | |
| 0.078 | 0.667 | 0.419 | 5 Hydroxytryptamine uptake stimulant | 0.419 0.011 DB12110 | DB12110 | |
| 0.01 | 0.599 | 0.117 | Polo-like kinase-4 inhibitor | 0.117 0.059 DB12110 | DB12110 | |
| 0.02 | 0.611 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 DB12110 | DB12110 | |
| 0.02 | 0.613 | 0.192 | 12-Lipoxygenase inhibitor | 0.192 0.161 DB12110 | DB12110 | |
| 0.03 | 0.626 | 0.196 | Hexokinase inhibitor | 0.196 0.037 DB12110 | DB12110 | |
| 0.005 | 0.602 | 0.077 | Cyclin A1 inhibitor | 0.077 0.016 DB12110 | DB12110 | |
| 0.026 | 0.627 | 0.096 | Glutamate (mGluR7) agonist | 0.096 0.069 DB12110 | DB12110 | |
| 0.006 | 0.608 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.035 DB12110 | DB12110 | |
| 0.005 | 0.609 | 0.036 | Protein kinase (CK2) beta inhibitor | 0.036 0.017 DB12110 | DB12110 | |
| 0.006 | 0.615 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.039 DB12110 | DB12110 | |
| 0.014 | 0.624 | 0.171 | Heat shock protein 90 alpha antagonist | 0.171 0.069 DB12110 | DB12110 | |
| 0.003 | 0.614 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 DB12110 | DB12110 | |
| 0.005 | 0.617 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 DB12110 | DB12110 | |
| 0.026 | 0.638 | 0.228 | 15-Lipoxygenase inhibitor | 0.228 0.184 DB12110 | DB12110 | |
| 0.024 | 0.637 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 DB12110 | DB12110 | |
| 0.012 | 0.625 | 0.169 | Ferrochelatase inhibitor | 0.169 0.031 DB12110 | DB12110 | |
| 0.004 | 0.62 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.088 0.016 DB12110 | DB12110 | |
| 0.026 | 0.644 | 0.099 | ABCA1 expression enhancer | 0.099 0.051 DBMET01712 | DBMET01712 | |
| 0.005 | 0.623 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.026 DB12110 | DB12110 | |
| 0.007 | 0.626 | 0.083 | Potassium channel (Voltage-sensitive) activator | 0.083 0.082 DB12110 | DB12110 | |
| 0.003 | 0.63 | 0.047 | Protein kinase (CK1) epsilon inhibitor | 0.047 0.016 DB12110 | DB12110 | |
| 0.002 | 0.636 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 DB12110 | DB12110 | |
| 0.014 | 0.648 | 0.08 | Glycine receptor agonist | 0.08 0.039 DB12110 | DB12110 | |
| 0.01 | 0.645 | 0.183 | GABA C receptor antagonist | 0.183 0.017 DB12110 | DB12110 | |
| 0.043 | 0.688 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.161 0.083 DB12110 | DB12110 | |
| 0.012 | 0.657 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 DB12110 | DB12110 | |
| 0.003 | 0.649 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.063 0.01 DB12110 | DB12110 | |
| 0.008 | 0.659 | 0.221 | Aryl hydrocarbon receptor agonist | 0.221 0.092 DB12110 | DB12110 | |
| 0.017 | 0.669 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.04 DB12110 | DB12110 | |
| 0.017 | 0.671 | 0.259 | DNA synthesis inhibitor | 0.259 0.061 DB12110 | DB12110 | |
| 0.061 | 0.718 | 0.222 | Nitric-oxide synthase stimulant | 0.222 0.058 DB12110 | DB12110 | |
| 0.012 | 0.669 | 0.181 | I kappa B kinase epsilon inhibitor | 0.181 0.088 DB12110 | DB12110 | |
| 0.004 | 0.664 | 0.059 | Cyclin A2 inhibitor | 0.059 0.048 DB12110 | DB12110 | |
| 0.022 | 0.683 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 DB12110 | DB12110 | |
| 0.001 | 0.664 | 0.011 | Imidazoline I2 receptor antagonist | 0.011 0.008 DB12110 | DB12110 | |
| 0.004 | 0.667 | 0.122 | Pim-3 kinase inhibitor | 0.122 0.03 DB12110 | DB12110 | |
| 0.005 | 0.669 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 DB12110 | DB12110 | |
| 0.013 | 0.679 | 0.109 | Cathepsin H inhibitor | 0.109 0.09 DB12110 | DB12110 | |
| 0.002 | 0.668 | 0.053 | Nicotinic alpha4beta2 receptor agonist | 0.053 0.004 DB12110 | DB12110 | |
| 0.004 | 0.674 | 0.055 | Cyclin A inhibitor | 0.055 0.048 DB12110 | DB12110 | |
| 0.001 | 0.677 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.037 0.004 DB12110 | DB12110 | |
| 0.003 | 0.679 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DB12110 | DB12110 | |
| 0.016 | 0.693 | 0.117 | Cell wall synthesis inhibitor | 0.117 0.103 DB12110 | DB12110 | |
| 0.021 | 0.7 | 0.273 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 DB12110 | DB12110 | |
| 0.004 | 0.684 | 0.032 | CDK4/cyclin D3 inhibitor | 0.032 0.016 DB12110 | DB12110 | |
| 0.022 | 0.703 | 0.139 | Aurora-C kinase inhibitor | 0.139 0.066 DB12110 | DB12110 | |
| 0.003 | 0.693 | 0.065 | Pim-2 kinase inhibitor | 0.065 0.027 DB12110 | DB12110 | |
| 0.009 | 0.704 | 0.164 | Protein kinase C mu inhibitor | 0.164 0.02 DB12110 | DB12110 | |
| 0.002 | 0.699 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DB12110 | DB12110 | |
| 0.009 | 0.709 | 0.233 | MAP kinase kinase 2 inhibitor | 0.233 0.062 DB12110 | DB12110 | |
| 0.005 | 0.712 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.051 DB12110 | DB12110 | |
| 0.017 | 0.728 | 0.174 | Peroxidase inhibitor | 0.174 0.067 DB12110 | DB12110 | |
| 0.003 | 0.715 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 DB12110 | DB12110 | |
| 0.004 | 0.717 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 DB12110 | DB12110 | |
| 0.009 | 0.729 | 0.121 | Cyclin-dependent kinase 7 inhibitor | 0.121 0.084 DB12110 | DB12110 | |
| 0.007 | 0.729 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.048 DB12110 | DB12110 | |
| 0.009 | 0.735 | 0.183 | Cyclin-dependent kinase 8 inhibitor | 0.183 0.049 DB12110 | DB12110 | |
| 0.005 | 0.737 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.014 DB12110 | DB12110 | |
| 0.001 | 0.735 | 0.055 | Nicotinic alpha3beta4 receptor agonist | 0.055 0.004 DB12110 | DB12110 | |
| 0.005 | 0.739 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.014 DB12110 | DB12110 | |
| 0.003 | 0.748 | 0.075 | Nav1.7 sodium channel blocker | 0.075 0.038 DB12110 | DB12110 | |
| 0.004 | 0.751 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 DB12110 | DB12110 | |
| 0.005 | 0.754 | 0.077 | I kappa B kinase inhibitor | 0.077 0.064 DB12110 | DB12110 | |
| 0.009 | 0.762 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 DB12110 | DB12110 | |
| 0.001 | 0.759 | 0.022 | Cyclin T1 inhibitor | 0.022 0.009 DB12110 | DB12110 | |
| 0.004 | 0.764 | 0.15 | LIM domain kinase 1 inhibitor | 0.15 0.098 DB12110 | DB12110 | |
| 0.01 | 0.774 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.023 DB12110 | DB12110 | |
| 0.012 | 0.777 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 DB12110 | DB12110 | |
| 0.005 | 0.771 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 DB12110 | DB12110 | |
| 0.004 | 0.777 | 0.036 | Integrin alpha2 antagonist | 0.036 0.026 DB12110 | DB12110 | |
| 0.013 | 0.791 | 0.181 | Transcription factor STAT inhibitor | 0.181 0.166 DB12110 | DB12110 | |
| 0.005 | 0.782 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.054 DB12110 | DB12110 | |
| 0.005 | 0.804 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 DB12110 | DB12110 | |
| 0.001 | 0.804 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DB12110 | DB12110 | |
| 0.006 | 0.811 | 0.199 | GABA C receptor agonist | 0.199 0.02 DB12110 | DB12110 | |
| 0.004 | 0.818 | 0.087 | Potassium channel activator | 0.087 0.064 DB12110 | DB12110 | |
| 0.016 | 0.832 | 0.216 | Insulysin inhibitor | 0.216 0.134 DB12110 | DB12110 | |
| 0.006 | 0.853 | 0.238 | Antibacterial | 0.238 0.189 DB12110 | DB12110 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |